Online citations, reference lists, and bibliographies.

Hepatocyte Nuclear Factor-4α Reverses Malignancy Of Hepatocellular Carcinoma Through Regulating MiR-134 In The DLK1-DIO3 Region.

Chuan Yin, Pei-qin Wang, Wen-ping Xu, Yuan Yang, Qing Zhang, Bei-fang Ning, Pingping Zhang, Weiping Zhou, Wei-Fen Xie, Wansheng Chen, Xiao-hong Zhang
Published 2013 · Biology, Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
UNLABELLED Hepatocyte nuclear factor-4α (HNF4α) is a dominant transcriptional regulator of hepatocyte differentiation and hepatocellular carcinogenesis. There is striking suppression of hepatocellular carcinoma (HCC) by HNF4α, although the mechanisms by which HNF4α reverses HCC malignancy are largely unknown. Herein, we demonstrate that HNF4α administration to HCC cells resulted in elevated levels of 28 mature microRNAs (miRNAs) from the miR-379-656 cluster, which is located in the delta-like 1 homolog (DLK1) -iodothyronine deiodinase 3 (DIO3) locus on human chromosome 14q32. Consistent with the reduction of HNF4α, these miRNAs were down-regulated in human HCC tissue. HNF4α regulated the transcription of the miR-379-656 cluster by directly binding to its response element in the DLK1-DIO3 region. Interestingly, several miRNAs in this cluster inhibited proliferation and metastasis of HCC cells in vitro. As a representative miRNA in this cluster, miR-134 exerted a dramatically suppressive effect on HCC malignancy by down-regulating the oncoprotein, KRAS. Moreover, miR-134 markedly diminished HCC tumorigenicity and displayed a significant antitumor effect in vivo. In addition, inhibition of endogenous miR-134 partially reversed the suppressive effects of HNF4α on KRAS expression and HCC malignancy. Furthermore, a positive correlation between HNF4α and miR-134 levels was observed during hepatocarcinogenesis in rats, and decreases in miR-134 levels were significantly associated with the aggressive behavior of human HCCs. CONCLUSION Our data highlight the importance of the miR-379-656 cluster in the inhibitory effect of HNF4α on HCC, and suggest that regulation of the HNF4α-miRNA cascade may have beneficial effects in the treatment of HCC.
This paper references
10.1016/j.cell.2011.10.043
An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis.
Maria Hatziapostolou (2011)
10.1158/0008-5472.CAN-09-4531
miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
Shuangni Yu (2010)
10.1136/gut.2008.174904
Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats
H-Y Yue (2009)
10.1038/nm.2834
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
E. Jiménez-Mateos (2012)
10.1242/dev.045724
Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene
Yunli Zhou (2010)
10.1002/hep.22510
Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
Chuan Yin (2008)
10.1158/1078-0432.CCR-07-1231
Altered MicroRNA Expression in Cervical Carcinomas
Jeong Won Lee (2008)
10.1158/0008-5472.CAN-08-2129
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Lena J. Chin (2008)
10.1002/path.2802
Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.
M. Castilla (2011)
10.1074/jbc.M111.229831
DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival
John Moon-Ching Luk (2011)
10.1073/pnas.0702177104
MicroRNA genes are frequently located near mouse cancer susceptibility loci
C. Sevignani (2007)
10.1016/j.ygeno.2005.09.018
High-resolution map and imprinting analysis of the Gtl2-Dnchc1 domain on mouse chromosome 12.
S. Tierling (2006)
10.1002/hep.23357
Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays.
Eugene Bolotin (2010)
10.1016/j.ajpath.2011.07.002
Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas.
Pornsuk Cheunsuchon (2011)
10.1186/1471-2164-9-346
Structural conservation versus functional divergence of maternally expressed microRNAs in the Dlk1/Gtl2 imprinting region
Martin Kircher (2008)
10.1186/1476-4598-5-29
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandrés (2006)
10.1016/j.bone.2011.10.012
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Venugopal Thayanithy (2012)
10.1073/pnas.0801615105
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
L. Zhang (2008)
10.1038/nature04367
A brain-specific microRNA regulates dendritic spine development
G. Schratt (2006)
10.1002/path.2610
Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster of co-expressed miRNAs located at 14q32.31.
F. Haller (2010)
10.1016/j.ejca.2010.02.043
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Linlang Guo (2010)
10.1634/STEMCELLS.2007-0295
MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1.
Y. Tay (2008)
10.1158/0008-5472.CAN-10-0824
Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Beifang Ning (2010)
10.2144/000112010
Facile means for quantifying microRNA expression by real-time PCR.
Rui Shi (2005)
10.1038/emboj.2009.10
Mef2-mediated transcription of the miR379–410 cluster regulates activity-dependent dendritogenesis by fine-tuning Pumilio2 protein levels
R. Fiore (2009)
10.1371/journal.pone.0002141
Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia
A. Dixon-Mciver (2008)
10.1371/journal.pone.0038847
Deregulated miRNAs in Hereditary Breast Cancer Revealed a Role for miR-30c in Regulating KRAS Oncogene
Miljana Tanić (2012)
10.1053/j.gastro.2006.01.006
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
D. Calvisi (2006)
10.1016/j.tig.2008.03.011
Genomic imprinting at the mammalian Dlk1-Dio3 domain.
S. T. da Rocha (2008)
10.4161/epi.3.4.6550
Molecular mechanisms regulating phenotypic outcome in paternal and maternal uniparental disomy for chromosome 14
T. Ogata (2008)
10.1038/nature09017
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells
M. Stadtfeld (2010)
10.1093/nar/gkm955
JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update
Jan Christian Bryne (2008)
10.1002/path.1928
Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
Tomoaki Tanaka (2006)
10.1073/pnas.0600246103
Hepatocyte nuclear factor 4alpha orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver.
M. Battle (2006)
10.1016/S1470-2045(09)70343-2
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.
T. Ueda (2010)
10.1038/onc.2008.474
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen (2009)
10.1074/jbc.M110.131995
Activation of the Imprinted Dlk1-Dio3 Region Correlates with Pluripotency Levels of Mouse Stem Cells*♦
Lei Liu (2010)
10.1002/hep.24280
The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
L. Santangelo (2011)
10.1093/nar/gkj112
miRBase: microRNA sequences, targets and gene nomenclature
S. Griffiths-Jones (2006)
10.1038/ng1175
Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis
F. Parviz (2003)
10.1007/s00018-012-1080-8
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis
Leonidas Benetatos (2012)
10.1038/nature07880
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
Yvonne Tay (2009)
10.1002/hep.20155
Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.
Natalia L. Lazarevich (2004)



This paper is referenced by
10.1093/carcin/bgy022
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS
Zhi-Liang Wang (2018)
10.1007/s13277-016-5027-9
MicroRNA-134 modulates glioma cell U251 proliferation and invasion by targeting KRAS and suppressing the ERK pathway
Yuguang Zhao (2016)
10.7150/thno.32344
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4α
Bai-Nan Zheng (2019)
10.1002/hep.27649
Low-molecular-weight fibroblast growth factor 2 attenuates hepatic fibrosis by epigenetic down-regulation of Delta-like1.
R. Pan (2015)
10.1186/s12943-018-0813-1
The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1
Chen-Hong Ding (2018)
10.17077/ETD.S8B7LLQI
A forward genetics approach to identify molecular drivers of liver cancer using Sleeping Beauty mouse models
Jesse D. Riordan (2013)
10.14800/SCE.726
HDAC9/miR-376a feed-forward loop drive tumorigenesis in hepatocellular carcinoma
Yongxia Zheng (2015)
10.1016/j.bbagrm.2014.03.010
An integrated approach for the identification of USF1-centered transcriptional regulatory networks during liver regeneration.
Huan Chen (2014)
10.1089/GTMB.2017.0179
Curcumin Suppresses In Vitro Proliferation and Invasion of Human Prostate Cancer Stem Cells by Modulating DLK1-DIO3 Imprinted Gene Cluster MicroRNAs
ZhangHu (2017)
10.3892/ol.2017.5644
MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
Xiaomei Su (2017)
MicroRNA-134 inhibits HCC cell growth and migration through the AKT / GSK 3 β / SNAIL signaling pathway
Shi-hai Liu (2016)
10.18632/oncotarget.5192
miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
Keith. O'Brien (2015)
10.1159/000362579
Hepatocellular Carcinoma: Basic and Transitional Research
Chuan Yin (2014)
10.1128/MCB.00213-18
Induction of Hepatic Metabolic Functions by a Novel Variant of Hepatocyte Nuclear Factor 4γ
Shota Sasaki (2018)
10.1016/j.gene.2016.12.030
MicroRNA-134-3p is a novel potential inhibitor of human ovarian cancer stem cells by targeting RAB27A.
C. F. Chang (2017)
10.1002/9783527674183.CH08
Predictive Toxicology: Genetics, Genomics, Epigenetics, and Next‐Generation Sequencing in Toxicology
Tobias Heckel (2014)
10.1038/emm.2016.177
Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma
B. Zhang (2017)
10.1111/1751-2980.12122
Differentiation therapy for solid tumors.
Wen ping Xu (2014)
10.1016/j.biopha.2020.109890
LncRNA MFI2-AS1 promotes HCC progression and metastasis by acting as a competing endogenous RNA of miR-134 to upregulate FOXM1 expression.
Yong-peng Wei (2020)
10.4254/wjh.v9.i4.191
Regulation of hepatic microRNA expression by hepatocyte nuclear factor 4 alpha
Hong Lu (2017)
10.1158/0008-5472.CAN-17-3896
SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Liang-zhi Wen (2018)
10.1074/jbc.M117.785592
An HNF4α–microRNA-194/192 signaling axis maintains hepatic cell function
Aoi Morimoto (2017)
10.1016/j.febslet.2014.12.002
MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins.
Yongtao Gao (2015)
10.1002/jcp.26430
miR‐542‐3p prevents ovariectomy‐induced osteoporosis in rats via targeting SFRP1
Xiguang Zhang (2018)
10.1002/hep.27287
MicroRNAs control hepatocarcinogenesis by regulating hepatocyte nuclear factor 4α-inflammatory signal feedback loops.
Hua Wang (2014)
10.2217/nnm-2016-0408
Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
Meiping Wang (2017)
10.1016/j.yexcr.2016.07.010
miR-106b-5p and miR-17-5p suppress osteogenic differentiation by targeting Smad5 and inhibit bone formation.
Tao Fang (2016)
10.1007/s00018-015-1970-7
Regulation of hepatocyte identity and quiescence
Carmen Berasain (2015)
10.1016/j.febslet.2013.07.030
miR-145 suppresses osteogenic differentiation by targeting Sp7.
Jie Jia (2013)
10.1016/j.jhep.2015.05.008
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Feng Rong Fang (2015)
10.7150/jca.17640
Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients
Yu Wang (2017)
10.1136/gutjnl-2019-318830
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagy
Wen-ping Xu (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar